Monopar Therapeutics Annual Return On Assets in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Monopar Therapeutics quarterly/annual Return On Assets history and growth rate from 2018 to 2023.
  • Monopar Therapeutics Return On Assets for the quarter ending September 30, 2024 was -87.8 %, a 1.77% decline year-over-year.
  • Monopar Therapeutics annual Return On Assets for 2023 was -88.2 %, a 31% decline from 2022.
  • Monopar Therapeutics annual Return On Assets for 2022 was -67.3 %, a 72.7% decline from 2021.
  • Monopar Therapeutics annual Return On Assets for 2021 was -39 %, a 6.21% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -88.2 -20.9 -31% Jan 1, 2023 Dec 31, 2023
2022 -67.3 -28.3 -72.7% Jan 1, 2022 Dec 31, 2022
2021 -39 +2.58 +6.21% Jan 1, 2021 Dec 31, 2021
2020 -41.6 +14 +25.2% Jan 1, 2020 Dec 31, 2020
2019 -55.6 -16.2 -41.2% Jan 1, 2019 Dec 31, 2019
2018 -39.4 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.